|[July 01, 2014]
Advanced Cell Technology, Inc. Announces Paul K. Wotton Ph.D. Recognized as Ernst & Young (EY) 2014 Entrepreneur of the Year™ for New Jersey Region
MARLBOROUGH, Mass. --(Business Wire)--
Advanced Cell Technology, Inc. ("ACT") (OTCBB:ACTC), a leader in the
field of regenerative medicine, today announced that Paul K. Wotton,
Ph.D. was the recipient of the 2014 Ernst and Young (EY) Entrepreneur Of
The Year™ Regional Award for the Life Sciences category in the New
Jersey region. The awards program recognizes entrepreneurs who
demonstrate excellence and extraordinary success in such areas as
innovation, financial performance and personal commitment to their
businesses and communities. Dr. Wotton was selected as the award winner
by a panel of independent judges and the award was presented at a gala
event at the Hyatt Regency in New Brunswick on June 26th 2014.
"I was honored to be selected as a finalist, and thrilled to be the
recipient of the 2014 EY Entrepreneur of The Year Regional Award," said
Paul K. Wotton, Ph.D., President and Chief Executive Officer. "I would
like to thank my former colleagues at Antares Pharma (NASDAQ:ATRS) for
their support as well as the organizers of this prestigious award for
making this all possible. I am now looking forward to working with my
new colleagues at ACT as we advance its age-related macular degeneration
(AMD (News - Alert)) and Stargardt's macular degeneration trials into phase 2."
Now in its 28th year, the program has expanded to recognize business
leaders in more than 145 cities in more than 60 countries throughout the
Regional award winners are eligible for consideration for the EY
Entrepreneur Of The Year National program. Award winners in several
national categories, as well as the EY�Entrepreneur Of The Year National
Overall Award winner, will be announced at the annual awards gala in
Palm Springs, California, on November 15, 2014. The awards are the
culminating event of the EY Strategic Growth Forum®, the nation's most
prestigious gathering of high-growth, market-leading companies.
Founded and produced by EY, the Entrepreneur Of The Year Awards are
sponsored in the United States by the Ewing Marion Kauffman Foundation
and SAP (News - Alert) America.
In New Jersey sponsors include DLA Piper, Merrill Corporation, Morgan
Lewis, PNC (News - Alert) Bank, Willis of New Jersey, Empire Valuation Consultants,
Scherzer International, SolomonEdwardsGroup, Cresa, Murray Devine, NJBIZ
About Advanced Cell Technology, Inc.
Advanced Cell Technology, Inc., (ACT) is a Marlborough, Mass.-based
biotechnology company focused on the development and commercialization
of human embryonic stem cell (hESC) and adult stem cell technology. The
company's most advanced products are in clinical trials for the
treatment of dry age-related macular degeneration, Stargardt's macular
degeneration and myopic macular degeneration. ACT's preclinical programs
involve cell therapies for the treatment of other ocular disorders and
for diseases outside the field of ophthalmology, including autoimmune,
inflammatory and wound healing-related disorders. The company's
intellectual property portfolio includes pluripotent stem cell platforms
- hESC and induced pluripotent stem cell (iPSC) - and other cell therapy
research programs. For more information, visit www.advancedcell.com.
About EY Entrepreneur Of The Year™
EY Entrepreneur Of The Year™ is the world's most prestigious business
award for entrepreneurs. The unique award makes a difference through the
way it encourages entrepreneurial activity among those with potential
and recognizes the contribution of people who inspire others with their
vision, leadership and achievement. As the first and only truly global
award of its kind, Entrepreneur Of The Year celebrates those who are
building and leading successful, growing and dynamic businesses,
recognizing them through regional, national and global awards programs
in more than 145 cities in more than 60 countries.
About EY's Strategic Growth Markets practice
EY's Strategic Growth Markets (SGM) practices guide leading high-growth
companies. Our multidisciplinary teams of elite professionals provide
perspective and advice to help our clients accelerate market leadership.
SGM delivers assurance, tax, transactions and advisory services to
thousands of companies spanning all industries. EY is the undisputed
leader in taking companies public, advising key government agencies on
the issues impacting high-growth companies and convening the experts who
shape the business climate. For more information, please visit us at ey.com/us/strategicgrowthmarkets,
or follow news on Twitter (News - Alert) @EY_Growth.
EY is a global leader in assurance, tax, transaction and advisory
services. The insights and quality services we deliver help build trust
and confidence in the capital markets and in economies the world over.
We develop outstanding leaders who team to deliver on our promises to
all of our stakeholders. In so doing, we play a critical role in
building a better working world for our people, for our clients and for
EY refers to the global organization, and may refer to one or more, of
the member firms of Ernst & Young Global Limited, each of which is a
separate legal entity. Ernst & Young Global Limited, a UK company
limited by guarantee, does not provide services to clients. For more
information about our organization, please visit ey.com.
[ InfoTech Spotlight's Homepage ]